Persistent lung inflammation and fibrosis in serum amyloid P component (APCs-/-) knockout mice.
Fibrosing diseases, such as pulmonary fibrosis, cardiac fibrosis, myelofibrosis, liver fibrosis, and renal fibrosis are chronic and debilitating conditions and are an increasing burden for the healthcare system. Fibrosis involves the accumulation and differentiation of many immune cells, including m...
Main Authors: | Darrell Pilling, Richard H Gomer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3973556?pdf=render |
Similar Items
-
Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice.
by: Tejas R Karhadkar, et al.
Published: (2021-01-01) -
The Development of Serum Amyloid P as a Possible Therapeutic
by: Darrell Pilling, et al.
Published: (2018-10-01) -
Serum Amyloid P Component Binds Fungal Surface Amyloid and Decreases Human Macrophage Phagocytosis and Secretion of Inflammatory Cytokines
by: Nicole E. Behrens, et al.
Published: (2019-03-01) -
C-reactive protein (CRP) but not the related pentraxins serum amyloid P and PTX3 inhibits the proliferation and induces apoptosis of the leukemia cell line Mono Mac 6
by: Wensheng Chen, et al.
Published: (2017-12-01) -
Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model
by: Tejas R. Karhadkar, et al.
Published: (2017-11-01)